2025. Study of the Efficacy and Safety of Stereotactic Radiation Therapy in Combination with Trastuzumab Emtansine Immunoconjugate in Patients with HER-2-positive Oligometastatic Breast Cancer. Interim Results. Voprosy onkologii. 71, 3 (Jun. 2025), OF-2347. DOI:https://doi.org/10.37469/0507-3758-2025-71-3-OF-2347.